GuillermoEUmpierrezMD

Endocrinology • Atlanta, GA

Diabetes, Lipid Metabolism

Professor of Medicine, Emory University

Join to view full profile

Dr. Umpierrez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Umpierrez's full profile

Already have an account?

Office
96 Armstrong St Se
Grady Health System - Endocrinology
Atlanta, GA 30303
Phone+1 404-616-3730

Education & Training

Emory University School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
Emory University School of MedicineResidency, Internal Medicine, 1982 - 1985
Universidad de Guayaquil, School of Medicine.Class of 1979

Certifications & Licensure

GA State Medical License 1984 - 2025
TN State Medical License 2000 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com
Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes Start of enrollment: 2005 Sep 01
Completed
Phase 4
Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU Start of enrollment: 2006 Jun 01
Completed
Not Applicable
Insulin Infusion in the Hospital Wards Start of enrollment: 2006 Aug 01
Completed
FFA-Induced Hypertension and Endothelial Dysfunction Start of enrollment: 2006 Aug 01
Completed
Not Applicable
Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA) Start of enrollment: 2007 Dec 01
Completed
Phase 4
Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery Start of enrollment: 2007 Dec 01
Completed
Phase 4
TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients Start of enrollment: 2007 Jun 01
Completed
Study on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPD Start of enrollment: 2006 Feb 01
Completed
Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation Start of enrollment: 2009 Jul 01
Completed
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN Start of enrollment: 2008 Nov 01
Completed
Phase 2, Phase 3
FFA Hypertension and Inflammation in Lean and Obese Subjects Start of enrollment: 2009 Apr 01
Completed
Not Applicable
Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes Start of enrollment: 2004 Mar 01
Completed
Phase 4
Diabetes in the Perioperative Period Start of enrollment: 2008 Aug 01
Completed
Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM) Start of enrollment: 2006 Apr 01
Terminated
Not Applicable
Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises Start of enrollment: 2004 Mar 01
Completed
Not Applicable
Emory Latino Diabetes Education Program Start of enrollment: 2008 Oct 01
Suspended
Effect of Thiazolidinediones on Human Bone Start of enrollment: 2009 Apr 01
Completed
Not Applicable
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2010 Jan 01
Completed
Phase 4
Diabetes Group Visits Start of enrollment: 2009 Nov 01
Completed
Lifestyle Intervention to Limit Excessive Weight Gain During Pregnancy in Minority Women Start of enrollment: 2010 Apr 01
Completed
Phase 4
Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment Start of enrollment: 2010 Mar 01
Completed
Phase 4
Diabetes in the Elderly: Retrospective Study Start of enrollment: 2010 May 01
Completed
Diabetes in the Elderly: Prospective Study Start of enrollment: 2011 Mar 01
Completed
Phase 4
Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery Start of enrollment: 2011 Jun 01
Completed
Phase 3
Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes Start of enrollment: 2011 Aug 01
Completed
Phase 4
Point-of-Care Glucose Testing and Insulin Supplementation Start of enrollment: 2012 May 01
Completed
Not Applicable
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese Start of enrollment: 2012 Dec 01
Terminated
Not Applicable
Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18
Terminated
Phase 2
Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients Start of enrollment: 2012 Oct 01
Completed
Phase 3
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes Start of enrollment: 2013 Aug 01
Completed
Phase 4
Liraglutide Hospital Discharge Trial Start of enrollment: 2014 Mar 01
Completed
Phase 4
Linagliptin Inpatient Trial Start of enrollment: 2014 Jan 01
Completed
Phase 4
ADA Linagliptin in Long Term Care Start of enrollment: 2014 Apr 25
Completed
Phase 4
Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers Start of enrollment: 2008 Jun 01
Completed
Phase 2, Phase 3
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes Start of enrollment: 2015 Sep 01
Completed
Phase 4
Glargine U300 Hospital Trial Start of enrollment: 2017 May 17
Completed
Phase 4
Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes Start of enrollment: 2018 Jan 02
Completed
Phase 4
Dexcom G6 Observational Study Start of enrollment: 2019 Feb 21
Completed
Not Applicable
Dexcom G6 Intervention Study Start of enrollment: 2019 Jun 26
Completed
Not Applicable
Dapagliflozin at Discharge on Hospital Heart Failure Readmission Start of enrollment: 2020 Jul 29
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings.
Julie L V Shaw, Raveendhara R Bannuru, Lori Beach, Nuha A ElSayed, Guido Freckmann
Diabetes Care. 2024-12-01
Managing blood glucose control in the intensive care unit.
Jan Gunst, Guillermo E Umpierrez, Greet Van den Berghe
Intensive Care Medicine. 2024-12-01
Caring for patients with diabetes in the outpatient surgical setting: current recommendations and controversies.
Elizabeth W Duggan, Guillermo E Umpierrez
Current Opinion in Anaesthesiology. 2024-12-01

Journal Articles

Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications
Sara C Auld, Guillermo E Umpierrez, J Sonya Haw, Current Diabetes Reports

Lectures

2019 Latin American Leadership Academy
ENDO 2019 - New Orleans, LA - 3/22/2019
Inpatient Diabetes Management: Show Me Some Sugar!
2019 ACP Internal Medicine Meeting, Philadelphia - 4/11/2019
Diabetes Care with Oral and Other Noninsulin Agents
2019 ACP Internal Medicine Meeting, Philadelphia - 4/11/2019
Insulin glargine/lixisenatide Fixed‐Ratio Combination Improves Glycaemic Variability and Control Without Increasing Hypoglycaemia
American Diabetes Association, 72nd Scientific Sessions, Philadelphia, Pennsylvania, USA
Insulin glargine/lixisenatide Fixed‐Ratio Combination Improves Glycaemic Variability and Control Without Increasing Hypoglycaemia
Atlanta, GA - 6/14/2014
Insulin glargine/lixisenatide Fixed‐Ratio Combination Improves Glycaemic Variability and Control Without Increasing Hypoglycaemia
Atlanta, GA - 6/15/2014
Insulin glargine/lixisenatide Fixed‐Ratio Combination Improves Glycaemic Variability and Control Without Increasing Hypoglycaemia
Atlanta, GA - 6/15/2014
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
72nd Scientific Sessions, Philadelphia, Pennsylvania, USA
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Atlanta, GA - 6/13/2014
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Atlanta, GA - 6/14/2014
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Atlanta, GA - 6/15/2014
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Atlanta, GA - 6/15/2014
Inpatient Diabetes Management: Goals, Challenges and Implications
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
Join now to see all

Press Mentions

Insulcloud Receives FDA Clearance to Expand Proprietary Diabetes Management Solution Insulclock® CAP into U.S. MarketOctober 29th, 2024
Sliding Scale Insulin for Inpatients Gets Some RespectNovember 10th, 2021
Dexcom CGM Plays Starring Role at 81st Scientific Sessions of the American Diabetes AssociationJune 25th, 2021
Join now to see all

Grant Support

Free Fatty Acids-Induced Hypertension And Endothelial Dysfunction In Obese SubjtNational Center For Research Resources2007
Beta-Cell Failure In Obese African-Americans With Hyperglycemic CrisisNational Center For Research Resources2006–2007
Hyperglycemia-Induced Insulin Resistance In Skeletal MuscleNational Center For Research Resources2005–2007
Markers Of Normoglycemic Remission In Obese DiabeticsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
Free Fatty Acids-Induced Hypertension In Obese Type 2 DiabeticsNational Center For Research Resources2005
Beta-Cell Failure In Hyperglycemic ObesityNational Center For Research Resources2005
Obese African-Americans With Dka: B-Cell DesensitizationNational Center For Research Resources2004
Differences In The Metabolic/Hormonal Profile In White/Black Women With PCOSNational Center For Research Resources2004

Committees

member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2036
member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015